MEND

New York, United States Founded: 2014 • Age: 12 yrs
Provider of dietary supplements to manage body immunity power

About MEND

MEND is a company based in New York (United States) founded in 2014.. MEND has raised $31.64 million across 8 funding rounds from investors including Colorcon, S2G Ventures and GenHenn Capital. MEND offers products and services including Repair & Recover: Surgery, Regenerate, Joint Replacement Support, and Control Glucose. MEND operates in a competitive market with competitors including EMN, Lanhao Biotech, Synofit, Collagen Msm Plus and Interpath Global, among others.

  • Headquarter New York, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Nutrition, Wellness & Lifestyle Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $31.64 M (USD)

    in 8 rounds

  • Latest Funding Round
    $9.86 M (USD), Series A

    Feb 05, 2026

  • Investors
    Colorcon

    & 7 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of MEND

MEND offers a comprehensive portfolio of products and services, including Repair & Recover: Surgery, Regenerate, Joint Replacement Support, and Control Glucose. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Supports tissue and bone healing after surgery or injury

Promotes healthy muscles and energy for daily performance

Protects muscles and aids faster recovery post-surgery

Maintains blood sugar levels for balanced energy and mood

People of MEND
Headcount 10-50
Employee Profiles 17
Board Members and Advisors 13
Employee Profiles
People
Helene Rutledge
Co-Founder & President
People
Eziah Syed
Co-Founder & CEO
People
Adam Tichelaar
Chief Technology Officer
People
Whitney Stevens
Co-Founder & Senior Strategist

Unlock access to complete

Board Members and Advisors
people
Robert Marx
Science Board Member
people
Lauren Antonucci
Science Board Member
people
Kevin Spelman
Science Board Member
people
Jason D. Bloom
Science Board Member

Unlock access to complete

Funding Insights of MEND

MEND has successfully raised a total of $31.64M across 8 strategic funding rounds. The most recent funding activity was a Series A round of $9.86 million completed in February 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 8
  • Last Round Series A — $9.9M
  • First Round

    (11 Mar 2020)

  • Investors Count 8
Date Amount Transaction Name Valuation Lead Investors Investors
Feb, 2026 Amount Series A - MEND Valuation

investors

Jun, 2025 Amount Series A - MEND Valuation

investors

Jun, 2025 Amount Debt – Conventional - MEND Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in MEND

MEND has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Colorcon, S2G Ventures and GenHenn Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Stage agnostic venture capital firm
Founded Year Domain Location
-
Founded Year Domain Location
-
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by MEND

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - MEND

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Mend Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of MEND

MEND operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as EMN, Lanhao Biotech, Synofit, Collagen Msm Plus and Interpath Global, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Clinical-grade nutrition products are developed for recovery and rehabilitation needs.
domain founded_year HQ Location
Oral regenerative restoration and medical aesthetics products are developed.
domain founded_year HQ Location
Provides natural supplements for joint, heart, and digestive health support.
domain founded_year HQ Location
Provides premium supplements for joint health using collagen, MSM, and essential vitamins.
domain founded_year HQ Location
Researches and develops joint health supplements for humans and animals globally.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Mend

Frequently Asked Questions about MEND

When was MEND founded?

MEND was founded in 2014 and raised its 1st funding round 6 years after it was founded.

Where is MEND located?

MEND is headquartered in New York, United States. It is registered at New York, New York, United States.

Is MEND a funded company?

MEND is a funded company, having raised a total of $31.64M across 8 funding rounds to date. The company's 1st funding round was a Series A of $1.5M, raised on Mar 11, 2020.

What does MEND do?

MEND was founded in 2014 in New York, United States, and operates in the dietary supplements sector. Supplements are developed to manage body immunity and aid repair and recovery after injuries or surgeries. Ingredients such as clinically studied proteins, amino acids, vitamins, minerals, and other nutrients are included to support healing. Products are made natural, gluten-free, and non-GMO, with distribution focused on health and wellness markets.

Who are the top competitors of MEND?

MEND's top competitors include EMN, Lanhao Biotech and Synofit.

What products or services does MEND offer?

MEND offers Repair & Recover: Surgery, Regenerate, Joint Replacement Support, and Control Glucose.

Who are MEND's investors?

MEND has 8 investors. Key investors include Colorcon, S2G Ventures, GenHenn Capital, KEEN Growth Capital, and Tech Council Ventures.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available